RBI-2000

N/A

Report date: 2026/05/12 09:10:28

Base Information

Drug NameRBI-2000

Drug Alias NameRBI-2000

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunomic Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunomic Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A